572 related articles for article (PubMed ID: 22021706)
1. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy.
Lin M; Yiu WH; Wu HJ; Chan LY; Leung JC; Au WS; Chan KW; Lai KN; Tang SC
J Am Soc Nephrol; 2012 Jan; 23(1):86-102. PubMed ID: 22021706
[TBL] [Abstract][Full Text] [Related]
2. The role of Toll-like receptor proteins (TLR) 2 and 4 in mediating inflammation in proximal tubules.
Mudaliar H; Pollock C; Komala MG; Chadban S; Wu H; Panchapakesan U
Am J Physiol Renal Physiol; 2013 Jul; 305(2):F143-54. PubMed ID: 23576640
[TBL] [Abstract][Full Text] [Related]
3. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.
Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS
Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934
[TBL] [Abstract][Full Text] [Related]
4. The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy.
Lin M; Yiu WH; Li RX; Wu HJ; Wong DW; Chan LY; Leung JC; Lai KN; Tang SC
Kidney Int; 2013 May; 83(5):887-900. PubMed ID: 23423259
[TBL] [Abstract][Full Text] [Related]
5. Expression and cellular distribution of TLR4, MyD88, and NF-κB in diabetic renal tubulointerstitial fibrosis, in vitro and in vivo.
Liu P; Li F; Qiu M; He L
Diabetes Res Clin Pract; 2014 Aug; 105(2):206-16. PubMed ID: 24894085
[TBL] [Abstract][Full Text] [Related]
6. Requirement for TLR2 in the development of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy.
Ma J; Wu H; Zhao CY; Panchapakesan U; Pollock C; Chadban SJ
Int J Clin Exp Pathol; 2014; 7(2):481-95. PubMed ID: 24551269
[TBL] [Abstract][Full Text] [Related]
7. TLR4 activation promotes podocyte injury and interstitial fibrosis in diabetic nephropathy.
Ma J; Chadban SJ; Zhao CY; Chen X; Kwan T; Panchapakesan U; Pollock CA; Wu H
PLoS One; 2014; 9(5):e97985. PubMed ID: 24842252
[TBL] [Abstract][Full Text] [Related]
8. Enhanced glomerular Toll-like receptor 4 expression and signaling in patients with type 2 diabetic nephropathy and microalbuminuria.
Verzola D; Cappuccino L; D'Amato E; Villaggio B; Gianiorio F; Mij M; Simonato A; Viazzi F; Salvidio G; Garibotto G
Kidney Int; 2014 Dec; 86(6):1229-43. PubMed ID: 24786705
[TBL] [Abstract][Full Text] [Related]
9. Blockade of HMGB1 Attenuates Diabetic Nephropathy in Mice.
Chen X; Ma J; Kwan T; Stribos EGD; Messchendorp AL; Loh YW; Wang X; Paul M; Cunningham EC; Habib M; Alexander IE; Sharland AF; Chadban SJ; Wu H
Sci Rep; 2018 May; 8(1):8319. PubMed ID: 29844451
[TBL] [Abstract][Full Text] [Related]
10. High Uric Acid-Induced Epithelial-Mesenchymal Transition of Renal Tubular Epithelial Cells via the TLR4/NF-kB Signaling Pathway.
Liu H; Xiong J; He T; Xiao T; Li Y; Yu Y; Huang Y; Xu X; Huang Y; Zhang J; Zhang B; Zhao J
Am J Nephrol; 2017; 46(4):333-342. PubMed ID: 29017152
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of toll-like receptor 2 in rat diabetic nephropathy.
Li F; Yang N; Zhang L; Tan H; Huang B; Liang Y; Chen M; Yu X
Am J Nephrol; 2010; 32(2):179-86. PubMed ID: 20628242
[TBL] [Abstract][Full Text] [Related]
12. Baicalin suppresses renal fibrosis through microRNA-124/TLR4/NF-κB axis in streptozotocin-induced diabetic nephropathy mice and high glucose-treated human proximal tubule epithelial cells.
Zhang S; Xu L; Liang R; Yang C; Wang P
J Physiol Biochem; 2020 Aug; 76(3):407-416. PubMed ID: 32500512
[TBL] [Abstract][Full Text] [Related]
13. Hyperuricemia-induced NLRP3 activation of macrophages contributes to the progression of diabetic nephropathy.
Kim SM; Lee SH; Kim YG; Kim SY; Seo JW; Choi YW; Kim DJ; Jeong KH; Lee TW; Ihm CG; Won KY; Moon JY
Am J Physiol Renal Physiol; 2015 May; 308(9):F993-F1003. PubMed ID: 25651569
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of S100A8/A9 ameliorates renal interstitial fibrosis in diabetic nephropathy.
Du L; Chen Y; Shi J; Yu X; Zhou J; Wang X; Xu L; Liu J; Gao J; Gu X; Wang T; Yin Z; Li C; Yan M; Wang J; Yin X; Lu Q
Metabolism; 2023 Jul; 144():155376. PubMed ID: 36521551
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein C3 aggravates diabetic nephropathy in type 1 diabetes by activating the renal TLR2/NF-κB pathway.
Wang H; Huang X; Xu P; Liu X; Zhou Z; Wang F; Li J; Wang Y; Xian X; Liu G; Huang W
Metabolism; 2021 Jun; 119():154740. PubMed ID: 33639183
[TBL] [Abstract][Full Text] [Related]
16. Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4/NF-κB signaling.
Han W; Ma Q; Liu Y; Wu W; Tu Y; Huang L; Long Y; Wang W; Yee H; Wan Z; Tang R; Tang H; Wan Y
Phytomedicine; 2019 Apr; 57():203-214. PubMed ID: 30785016
[TBL] [Abstract][Full Text] [Related]
17. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes.
Devaraj S; Tobias P; Jialal I
Cytokine; 2011 Sep; 55(3):441-5. PubMed ID: 21498084
[TBL] [Abstract][Full Text] [Related]
18. Increased macrophage activation inhibited by tacrolimus in the kidney of diabetic rats.
Wu Y; Wang Y; Qi X; Zhang P; Zhang C; Zhang W
Nephron Exp Nephrol; 2014; 128(1-2):46-56. PubMed ID: 25376933
[TBL] [Abstract][Full Text] [Related]
19. Dapagliflozin ameliorates diabetic renal injury through suppressing the self-perpetuating cycle of inflammation mediated by HMGB1 feedback signaling in the kidney.
Yuan Y; Sun M; Jin Z; Zheng C; Ye H; Weng H
Eur J Pharmacol; 2023 Mar; 943():175560. PubMed ID: 36736941
[TBL] [Abstract][Full Text] [Related]
20. High glucose induces toll-like receptor expression in human monocytes: mechanism of activation.
Dasu MR; Devaraj S; Zhao L; Hwang DH; Jialal I
Diabetes; 2008 Nov; 57(11):3090-8. PubMed ID: 18650365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
